These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27622699)

  • 61. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.
    Agustí A; de Teresa L; De Backer W; Zvarich MT; Locantore N; Barnes N; Bourbeau J; Crim C
    Eur Respir J; 2014 Mar; 43(3):763-72. PubMed ID: 24114969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
    Jenkins C; Woolcock AJ; Saarelainen P; Lundback B; James MH
    Respir Med; 2000 Jul; 94(7):715-23. PubMed ID: 10926345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
    Bleecker ER; Welch MJ; Weinstein SF; Kalberg C; Johnson M; Edwards L; Rickard KA
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1123-9. PubMed ID: 10856145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome.
    Ishiura Y; Fujimura M; Shiba Y; Ohkura N; Hara J; Kasahara K
    Pulm Pharmacol Ther; 2015 Dec; 35():28-33. PubMed ID: 26497109
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Propionate Study Group.
    Katz Y; Lebas FX; Medley HV; Robson R
    Clin Ther; 1998; 20(3):424-37. PubMed ID: 9663359
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.
    Bleecker ER; Lötvall J; O'Byrne PM; Woodcock A; Busse WW; Kerwin EM; Forth R; Medley HV; Nunn C; Jacques L; Bateman ED
    J Allergy Clin Immunol Pract; 2014; 2(5):553-61. PubMed ID: 25213048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
    Bremner PR; Birk R; Brealey N; Ismaila AS; Zhu CQ; Lipson DA
    Respir Res; 2018 Jan; 19(1):19. PubMed ID: 29370819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.
    Oliver A; VanBuren S; Allen A; Hamilton M; Tombs L; Inamdar A; Kempsford R
    Clin Ther; 2014 Jun; 36(6):928-939.e1. PubMed ID: 24793536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED; Silins V; Bogolubov M
    Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
    Currie GP; Stenback S; Lipworth BJ
    Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction.
    Martin N; Weiler JM; Pearlman D; Jacques L; Nunn C; Forth R; West S; Dunn K; O'Byrne PM
    J Asthma; 2020 Apr; 57(4):431-440. PubMed ID: 30795705
    [No Abstract]   [Full Text] [Related]  

  • 78. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
    Ringdal N; Eliraz A; Pruzinec R; Weber HH; Mulder PG; Akveld M; Bateman ED;
    Respir Med; 2003 Mar; 97(3):234-41. PubMed ID: 12645830
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study.
    Jacques L; Bakerly ND; New JP; Svedsater H; Lay-Flurrie J; Leather DA
    J Asthma; 2019 Jul; 56(7):748-757. PubMed ID: 29972089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.